Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
120,194,336
-
Share change
-
+549,152
-
Total reported value
-
$33,292,114,949
-
Put/Call ratio
-
120%
-
Price per share
-
$276.92
-
Number of holders
-
998
-
Value change
-
+$172,014,088
-
Number of buys
-
420
-
Number of sells
-
433
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q4 2022
As of 31 Dec 2022 BIOGEN INC. - COM (BIIB) had 998 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 120,194,336 shares of stock of the company.
Largest 10 holders included PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, DEUTSCHE BANK AG\, Clearbridge Investments, LLC, D. E. Shaw & Co., Inc., and NORTHERN TRUST CORP.
This table shows 1,011 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.